We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Marrone Bio Innovations Inc | NASDAQ:MBII | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.7981 | 0.7803 | 0.80 | 0 | 01:00:00 |
FORM 4
[X]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * Ospraie Ag Science LLC | 2. Issuer Name and Ticker or Trading Symbol MARRONE BIO INNOVATIONS INC [ MBII ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner _____ Officer (give title below) __X__ Other (specify below) (See Remarks) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock, $0.00001 par value | 7/12/2022 | U | 70836258 | D | (1) | 0 | D (2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Remarks: Each of Ospraie Ag Science LLC, Ospraie Management, LLC, Ospraie Holding I, LP, Ospraie Management, Inc., OAS MM, LLC and Dwight Anderson (collectively, the "Reporting Persons") may be deemed a director by deputization of Marrone Bio Innovations, Inc. (the "Issuer") by virtue of the fact that Messrs. Robert A. Woods, Yogesh Mago, Keith McGovern and Stuart Woolf, representatives of the Reporting Persons, served on the board of directors of the Issuer prior to the closing of the merger contemplated by the Merger Agreement. |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Ospraie Ag Science LLC C/O DWIGHT ANDERSON 411 THEODORE FREMD AVENUE, SUITE 240 RYE, NY 10580 | X | X | (See Remarks) | ||
Ospraie Management, LLC 411 THEODORE FREMD AVENUE, SUITE 240 RYE, NY 10580 | X | X | (See Remarks) | ||
Anderson Dwight 411 THEODORE FREMD AVENUE, SUITE 240 RYE, NY 10580 | X | X | (See Remarks) | ||
Ospraie Holding I, L.P. 411 THEODORE FREMD AVENUE, SUITE 240 RYE, NY 10580 | X | X | (See Remarks) | ||
Ospraie Management, Inc. 411 THEODORE FREMD AVENUE, SUITE 240 RYE, NY 10580 | X | X | (See Remarks) |
Signatures | ||
OSPRAIE AG SCIENCE LLC By: OAS MM, LLC, its managing member Name: /s/ Dwight Anderson Title: Managing Member | 7/15/2022 | |
**Signature of Reporting Person | Date | |
OSPRAIE MANAGEMENT, LLC By: Ospraie Holding I, L.P., its managing member By: Ospraie Management, Inc., its general partner Name: /s/ Dwight Anderson Title: Sole Owner | 7/15/2022 | |
**Signature of Reporting Person | Date | |
OSPRAIE HOLDING I, LP By: Ospraie Management, Inc. its general partner Name: /s/ Dwight Anderson Title: Sole Owner | 7/15/2022 | |
**Signature of Reporting Person | Date | |
OSPRAIE MANAGEMENT, INC. Name: /s/ Dwight Anderson Title: Sole Owner | 7/15/2022 | |
**Signature of Reporting Person | Date | |
DWIGHT ANDERSON Name: /s/ Dwight Anderson | 7/15/2022 | |
**Signature of Reporting Person | Date | |
OAS MM, LLC Name: /s/ Dwight Anderson Title: Managing Member | 7/15/2022 | |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Marrone Bio Innovations Chart |
1 Month Marrone Bio Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions